Han-Jun Kim Selected Research

soyasaponin Ab

1/2018

Germinated soy germ with increased soyasaponin Ab improves BMP-2-induced bone formation and protects against in vivo bone loss in osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Jun Kim Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 08/2002
3	Inflammation (Inflammations) 01/2021 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2022 - 08/2020
2	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2017
2	Fibrosis (Cirrhosis) 12/2021 - 01/2021
2	Osteoporosis 01/2018 - 12/2014
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Fatty Liver 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Thrombosis (Thrombus) 10/2020
1	Infections 08/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hemorrhage 01/2020
1	Hypertrophy 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 12/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2019
1	Weight Gain 02/2019
1	Disease Progression 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Cerebral Hemorrhage 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Brain Edema (Cerebral Edema) 01/2018
1	Postmenopausal Osteoporosis 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Hemangiosarcoma (Angiosarcoma) 01/2017
1	Bone Resorption 01/2016
1	Parkinson Disease (Parkinson's Disease) 02/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 01/2020
2	HydrogelsIBA 01/2022 - 01/2021
2	Biological ProductsIBA 11/2021 - 01/2016
2	Caspase 3 (Caspase-3)IBA 01/2020 - 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	GelatinIBA 01/2022
1	CollagenIBA 12/2021
1	Keratins (Keratin)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	VimentinIBA 12/2021
1	AntigensIBA 11/2021
1	EstersIBA 01/2021
1	polydopamineIBA 01/2021
1	AntibodiesIBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	LipidsIBA 01/2021
1	EnzymesIBA 10/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2020
1	PlasminogenIBA 10/2020
1	Fibrinolysin FDA Link 10/2020
1	Nucleic AcidsIBA 08/2020
1	DNA (Deoxyribonucleic Acid)IBA 08/2020
1	monodansylcadaverineIBA 01/2020
1	Beclin-1IBA 01/2020
1	CurcuminIBA 01/2020
1	MetalsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Sirtuin 1IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	Conditioned Culture MediaIBA 12/2019
1	CytokinesIBA 12/2019
1	LDL CholesterolIBA 02/2019
1	Triglycerides (Triacylglycerol)IBA 02/2019
1	soyasaponin AbIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	HydrogenIBA 01/2018
1	gadoteridol (Prohance)FDA Link 01/2018
1	GadoliniumIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	GoldIBA 01/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	alpha-SynucleinIBA 02/2007
1	oregoninIBA 08/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2018
2	Injections 01/2022 - 01/2021
2	Electrodes (Electrode) 01/2022 - 01/2016
1	Bioreactors (Bioreactor) 01/2021
1	Immunotherapy 01/2021
1	Cyclotrons 01/2018
1	Neutron Capture Therapy 01/2018
1	Osteotomy 01/2017
1	Ovariectomy (Oophorectomy) 12/2014